These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3533617)

  • 1. [General patterns in the action of psychotropic agents].
    Karkishchenko NN
    Farmakol Toksikol; 1986; 49(5):45-50. PubMed ID: 3533617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiological aspects in the mechanism of action of some psychotropic drug agents].
    Radev R
    Eksp Med Morfol; 1976; 15(1):46-52. PubMed ID: 1269463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of pharmacodynamic measurements in the assessment of bioavailability and bioequivalence of psychotropic drugs using CEEG and dynamic brain mapping.
    Itil TM; Itil KZ
    J Clin Psychiatry; 1986 Sep; 47 Suppl():20-7. PubMed ID: 3528132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of different classes of psychotropic substances on 14C-glutamate uptake by crude synaptosomal fractions in the rat brain].
    Gankina EM; Avdulov NA; Maĭsov NI
    Farmakol Toksikol; 1982; 45(6):17-20. PubMed ID: 7151994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological effects of combinations of psychotropic preparations used in combined pharmacotherapy].
    Zimakova IE; Baĭchurina AZ; Zimakov IuA
    Farmakol Toksikol; 1987; 50(1):8-10. PubMed ID: 3556558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of psychotropic drugs on the animal EEG: electrophysiological analysis of the effects of psychotropic drugs.
    Yamaguchi N; Yoshimoto H; Kubota M; Ito T; Nakamura K
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():566-76. PubMed ID: 6962043
    [No Abstract]   [Full Text] [Related]  

  • 7. [From the pharmacology of drugs to their use: formation of knowledge about psychotropic drugs].
    Montagne M
    Sante Ment Que; 1997; 22(1):149-63. PubMed ID: 9233276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some examples for the possibilities and limitations of pharmacoelectroencephalography as a method in clinical pharmacology.
    Herrmann WM
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():55S-76S. PubMed ID: 6119408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurophysiological aspects of psychopharmacology (a review of the foreign literature)].
    Paniushkina SV
    Farmakol Toksikol; 1980; 43(6):736-40. PubMed ID: 6108869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pupillometry in psychopharmacologic experiments].
    Grünberger J; Linzmayer L; Cepko H; Saletu B
    Arzneimittelforschung; 1986; 36(1):141-6. PubMed ID: 3954817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology.
    Donovan JL; DeVane CL
    Psychopharmacol Bull; 2001; 35(3):30-48. PubMed ID: 12397877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methodologic aspects in psychopharmacology].
    Kaumeier HS
    Methods Find Exp Clin Pharmacol; 1982; 4(7):539-42. PubMed ID: 6763118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A general biological hypothesis on the mechanisms of the effect of different psychotropic agents that optimize memory].
    Tushmalova NA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(1):3-7. PubMed ID: 7513486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of the action of psychotropic preparations on transport ATPases].
    Lavretskaia EF; Tat'ianenko LV; Moshkovskiĭ IuSh; Raĭkhman LM; Kotel'nikova RV
    Farmakol Toksikol; 1980; 43(3):292-5. PubMed ID: 6450055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.
    Saletu B; Grünberger J; Flener R; Linzmayer L; Sieroslawski H
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):810-21. PubMed ID: 827426
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of new 9-(omega-[4-(2-pyrimidinyl)-1-piperazinyl]alkyl) pyrimidino[2,1-f]purines on the central nervous system.
    Malec D; Modzelewski J; Drabczyńska A; Pawłowski M; Gorczyca M
    Pol J Pharmacol; 1995; 47(2):169-73. PubMed ID: 8688890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A neurophysiological analysis of the action of psychostimulant agents].
    Krapivin SV; Morozov IS
    Eksp Klin Farmakol; 1994; 57(5):66-72. PubMed ID: 7696911
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Possibility of predicting the effect of psychotropic drugs on the EEG.
    Tosovský J; Hynek K
    Act Nerv Super (Praha); 1975; 17(4):293. PubMed ID: 1221804
    [No Abstract]   [Full Text] [Related]  

  • 19. Voltage-operated calcium channels: characteristics and their role in the mechanism of action of psychotropic drugs.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 1999; 51(2):179-86. PubMed ID: 10425648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Computed analysis of brain electrograms under the action of psychotropic drugs].
    Omel'chenko VP; Matua SP; Grishin AD
    Farmakol Toksikol; 1989; 52(3):18-22. PubMed ID: 2792348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.